Categories Analysis, Consumer

Key takeaways from Altria’s (MO) Q3 2025 earnings report

Altria now expects adjusted EPS of $5.37-5.45 for full-year 2025

Shares of Altria Group, Inc. (NYSE: MO) fell 6% on Thursday after the company released its third quarter 2025 earnings results. Revenues missed expectations while earnings came in line. The company raised its guidance for the full year of 2025. Here are the main takeaways from the report:

Revenue decline, earnings growth

In Q3 2025, Altria’s net revenues decreased 3% year-over-year to $6 billion, mainly due to lower revenues in both its segments. Reported earnings per share increased 5.2% to $1.41. Adjusted EPS rose 4% to $1.45.  

Segment revenue declines

In Q3, revenues in the Smokeable Products segment decreased nearly 3% YoY to $5.4 billion, mainly due to lower shipment volume and higher promotional investments, partly offset by higher pricing. Domestic cigarette shipment volume fell 8.2%, mainly due to the growth of disposable e-vapor products and discretionary income pressures on customers. Discretionary income pressures have led to growth in the discount segment, where there appears to be room for expansion in an inflationary environment.

Marlboro’s retail share of the total cigarette category dropped by 1.2 share points to 40.4%. The brand’s share of the premium segment grew by 0.3 share points to 59.6%.

Revenues in the Oral Tobacco Products segment declined nearly 5% to $689 million, driven by lower shipment volume and a higher percentage of on! shipment volume relative to MST versus the prior year, partly offset by higher pricing. Domestic shipment volume fell 9.6% in the quarter.

In the US, the nicotine pouch category grew to 55.7% of the oral tobacco category, up 11.1 share points YoY. on!’s share of the nicotine pouch category dropped 4.1 share points to 15.6%.

Raised outlook

Altria raised the lower end of its outlook for full-year 2025 and now expects adjusted EPS of $5.37-5.45, which represents YoY growth of 3.5-5.0%.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Citigroup set to report Q4 2025 earnings. Here’s what to expect

Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the

Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon

Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top